Search PubMed⌕ Search

Biomedical subjects

J Paty

Publications and source records attributed to J Paty.

At least 37 records · Page 2Linked to original sources
PubMed1978

[Evoked potentials in movement epilepsy (a report on 4 observations) (author's transl)].

A study of evoked potentials; visual (V.E.P.) auditory (A.E.P), and somatosensorial (S.E.P.) in 4 cases of movement epilepsy. Their correlation to clinical findings (provoking factors, control of the attacks), electroencephalographic and neuroradiological (scanner) data, shows that two types of information can be obtained: lesional and functional. Three types of modification can be described: a) the topographically limited changes in E.P. depend on lesional localization; b) the increase in amplitude of the late components and of the post-discharge of the E.P. ("paroxystical" aspect) appear to be a characteristic common to all epilepsies, whatever the mechanism; c) the abnormal exaggeration of the E.P. during voluntary movement seems to be a dynamic element peculiar to movement epilepsy. The information given by E.P.'s in some well-defined cases of epilepsy suggest that it is possible to draw conclusions from tests of the capacity for sensory-motor control to enable functional therapy of some attacks.

Adolescent↗
PubMed1978

Neurophysiological study of 47, XYY and 47, XXY psychopaths: contingent negative variation, evoked potentials and motor nerve conduction.

Neurophysiological investigations-including sensory-evoked responses, contingent negative variation (CNV), and nerve conduction velocities-were done in 11 male polygonosomic patients and in comparison with a control group. Some significant data are reported pointing out differences which may be related to a hypovigil type (47, XYY) and a hypervigil type (47, XXY). The importance of the CNV and conduction velocity as an index of a constitutional minimal brain dysfunction is discussed.

Adult↗
PubMed1978

[Electrophysiologic aspects of the effects of etomidate in man].

Recordings were electroencephalographical (EEG with spectral analysis), polygraphical (EMG, EKG, breathing). Visual and Auditory Cerebral Evoked Responses were also recorded. The depth of narcosis was quantified upon EEG data. The reactivity during the narcosis and the mechanisms of action of Etomidate on the "non specific structures" are discussed. Cautions should be taken with the use of tomidate in anesthesiology with epileptic and arteriopathic patients.

Adult↗
PubMed1978

[A case of Jakob-Creutzfeldt's disease (form of Heidenhain) electrophysiological, clinical and anatomical correlations (author's transl)].

We report a case of Jakob-Creutzfeldt's disease (amaurotic form of Heidenmain's disease) showing typical clinical, anatomical, microscopic and electrophysiologic (E.E.G, polygraph sleep recordings, Evoked Potential) signs. Changes in visual Evoked Potentials were quite specific whereas Auditory and Somesthesic E.P'. were not modified. Early elements (O, I, II, and III having a latency of less than 100 ms) were strongly developed, while later elements of the associative type were absent. The precociousness and specificity of the E.P. abnormalities are stressed in the differential diagnosis of J.-C's disease from other insanities, or from cortical blindness of other aetiology. The physiopathologic implications of electrophysiological data is discussed to illustrate the possibility of using Evoked Potentials to help resolve the problems of functional cerebral stratigraphy in man.

Aged↗
PubMed1978

[Risk of psychotropic drug potentiation by dipropylacetamide (16 cases)].

We report 16 cases in which there is a dangerous potentialization of psychotropic drugs with dipropylacetamide, and compare them with 19 cases possible to control, that dipropylacetamide used alone, or in another association, was well tolerated. We pointed out the importance of a depressive evolution, and of dangerous associations, mainly with tricyclic compounds, lorazepam and 5-hydroxytryptamine. Clinical signs are described; they consist in a fast evolutive syndrome, which is the same that "syndrome malin of psychotrops" with neurovegetative signs and central fever, or ingravescent wakefulness disorders and spasmodic cerebellar signs. The importance for the diagnosis and the prognosis of E.E.G. data is pointed out; plasma levels determination does not seem to give important data. Drugs interactions studies are very important in the clinical evaluation of psychotrops. Several drugs may interact with dipropylacetamide. This fact sustains some hypothesises about the action site of the drug.

Adult↗
PubMed1977

[Study of a new anesthetic agent: etomidate (R 26490). Electroencephalographic aspects].

Etomidate or R 26490 is a new hypnotic agent produced by JANSSEN and al. in 1971. The first human experimentation was performed in 1972. The authors used Etomidate for 300 anaesthetics given for neuroradiological investigations. Two protocols were used for study: 25 anaesthetics were given with Etomidate as sole anaesthetic to outline its specific properties; 275 angiographies were performed with a combination of Etomidate and fentanyl. In protocol no. 1, the mean consumption was for 1,85 mg/kg/h, in protocol no. 2, the mean consumption was of 0,9 mg/kg/h. Pharmacological study of this drug defines it as a short acting hypnotic agent of low toxicity. Clinical observation shows cardiovascular and respiratory stability. However, frequent myoclonias were noted, when Etomidate was given as a sole anaesthetic. EEG recording and evoked response encephalography helped to outline some effects of Etomidate on central nervous system.

Adolescent↗
PubMed1976

[Study of a new anesthetic agent: Etomidate (R 26490). Unusual electroencephalic aspects].

Etomidate or R 26490 is a new hypnotic agent produced by JANSSEN and al. in 1971. The first human experimentation was performed in 1972. The authors used Etomidate for 300 anaesthetics given for neuroradiological investigations. Two protocols were used for study: 25 anaesthetics were given with Etomidate as sole anaesthetic to outline its specific properties; 275 angiographies were performed with a combination of Etomidate and fentany1. In protocol no 1, the mean consumption was for 1,85 mg/kg/h, in protocol no2, the mean consumption was of 0,9 mg/kg/h. Pharmacological study of this drug defines it as a short acting hypnotic agent of low toxicity. Clinical observation shows cardiovascular and respiratory stability. However, frequent myoclonias were noted, when Etomidate was given as a sole anaesthetic. EEG recording and evoked response encephalography helped to outline some effects of Etomidate on central nervous system.

Adolescent↗